Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

Figure 3

Kaplan-Meier survival curves according to MGMT and/or CD133 expression in colorectal adenocarcinoma patients. (A) OS curves for different MGMT expression intensity scores. (B) DFS curves for different percentage CD133 expression scores. (C) OS curves for different MGMT and CD133 scores when analyzed together and (D) DFS curves for different MGMT and CD133 scores when analyzed together.

Back to article page
\